Engitix Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform. | ![]() Abterra Biosciences Abterra Biosciences (formerly Digital Proteomics) is a company engaged in antibody discovery and sequencing using NGS (next-generation sequencing) and mass spectrometry. | ||||
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2015 | Founding Date 2016 | Founding Date 2009 |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Emeryville, US HQ | Locations London, GB HQ New York, US New York, US | Locations Villigen, CH HQ | Locations Cambridge, US HQ London, GB London, GB | Locations San Diego, US HQ |
Employees | Employees 223 | Employees 19 | Employees N/A | Employees 542% increase | Employees 11 |
Funding | |||||
Total funding raised | Total funding raised $ 74.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.4m | Total funding raised N/A |

Eleusis is a company developing the therapeutic potential of serotonin 2A receptor agonists.
View companyleadXpro is a discovery company focusing on membrane protein drug targets.
View companyEngitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform.
View company
Abterra Biosciences (formerly Digital Proteomics) is a company engaged in antibody discovery and sequencing using NGS (next-generation sequencing) and mass spectrometry.
View company